Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-12 6:11 pm Sale | 13G | MEDICUS SCIENCES ACQUISITION C MSAC | First Trust Capital Management L.P. | 0 0% | -680,603 (Position Closed) | View |
| 2024-02-08 2:19 pm Sale | 13G | MEDICUS SCIENCES ACQUISITION C MSAC | Saba Capital Management L.P. | 0 0% | -817,821 (Position Closed) | View |
| 2023-02-14 4:33 pm Sale | 13G | MEDICUS SCIENCES ACQUISITION C MSAC | D. E. SHAW & CO L.P. | 459,500 4.9% | -74,496 (-13.95%) | View |
| 2023-02-14 1:14 pm Purchase | 13G | MEDICUS SCIENCES ACQUISITION C MSAC | GLAZER CAPITAL LLC | 902,871 9.72% | 902,871 (New Position) | View |
| 2023-02-14 12:05 pm Purchase | 13G | MEDICUS SCIENCES ACQUISITION C MSAC | First Trust Capital Management L.P. | 680,603 7.32% | 680,603 (New Position) | View |
| 2023-02-10 4:47 pm Sale | 13G | MEDICUS SCIENCES ACQUISITION C MSAC | Third Point LLC | 0 0% | -790,000 (Position Closed) | View |
| 2023-01-24 2:40 pm Sale | 13G | MEDICUS SCIENCES ACQUISITION C MSAC | Cowen Financial Products LLC | 0 0% | -500,000 (Position Closed) | View |
| 2022-03-11 10:06 am Purchase | 13G | MEDICUS SCIENCES ACQUISITION C MSAC | Cowen Financial Products LLC | 500,000 5.38% | 500,000 (New Position) | View |
| 2022-02-14 4:22 pm Purchase | 13G | MEDICUS SCIENCES ACQUISITION C MSAC | Third Point LLC | 790,000 8.5% | 790,000 (New Position) | View |
| 2022-02-14 4:16 pm Purchase | 13G | MEDICUS SCIENCES ACQUISITION C MSAC | Medicus Sciences Holdings LLC | 2,323,000 20% | 2,323,000 (New Position) | View |
| 2022-02-14 10:32 am Sale | 13G | MEDICUS SCIENCES ACQ CORP MSACU | HealthCor Management L.P. | 0 0% | -790,000 (Position Closed) | View |
| 2022-02-14 08:14 am Purchase | 13G | MEDICUS SCIENCES ACQUISITION C MSAC | Saba Capital Management L.P. | 817,821 8.8% | 285,359 (+53.59%) | View |
| 2022-01-18 4:04 pm Purchase | 13G | MEDICUS SCIENCES ACQUISITION C MSAC | D. E. SHAW & CO L.P. | 533,996 5.7% | 533,996 (New Position) | View |
| 2021-08-05 4:26 pm Purchase | 13G | MEDICUS SCIENCES ACQUISITION C MSAC | Saba Capital Management L.P. | 532,462 5.7% | 532,462 (New Position) | View |
| 2021-03-01 4:06 pm Purchase | 13G | MEDICUS SCIENCES ACQ CORP MSACU | ADAGE CAPITAL PARTNERS GP L.L.C. | 790,000 8.5% | 790,000 (New Position) | View |
| 2021-02-26 4:00 pm Purchase | 13G | MEDICUS SCIENCES ACQ CORP MSACU | HealthCor Management L.P. | 790,000 8.5% | 790,000 (New Position) | View |